NCT02802241View on ClinicalTrials.gov

Effects of Open-label vs Double-blind Treatment in IBS

NACompletedINTERVENTIONAL
Enrollment

340

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

January 31, 2019

Study Completion Date

January 31, 2019

Conditions
Irritable Bowel SyndromePlacebo EffectPlacebosPeppermint Oil
Interventions
DRUG

placebo

DIETARY_SUPPLEMENT

peppermint oil

Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

lead

Beth Israel Deaconess Medical Center

OTHER

NCT02802241 - Effects of Open-label vs Double-blind Treatment in IBS | Biotech Hunter | Biotech Hunter